| Merck Heads Back to India for More Anti-Infective Programmes |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
| Merck Signs Osteoporosis Deal with Japan Tobacco |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Astellas Receives Worldwide Commercial Rights to Major Preclinical Programme |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
| CV Therapeutics Aims High Through its Agreement with Menarini |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
| Cellzome’s Billion Dollar Deal with GSK |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Ablynx’s Nanobodies® Take in Another Big Pharma |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
| Medivation and Pfizer to Partner on Alzheimer’s Drug |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Sanofi-aventis Gains Zentiva With Sweeter Offer |
Abstract
html
|
|
Taskin Ahmed |
|
| Protherics Agrees to Takeover by BTG |
Abstract
html
|
|
Helen Scrutton |
|
| Bayer’s Foray into Biotech |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Shionogi Keeps Up with Latest Japanese Pharma Trend |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
| Novacea Rescued by Transcept |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Teva and Kowa to Create Leading Generics Business in Japan |
Abstract
pdf
html
|
|
Helen Scrutton |
|
| Will Lehman’s Collapse Affect the Pharmaceutical Industry? |
Abstract
html
|
|
Fintan Walton |
|
